241 related articles for article (PubMed ID: 25603416)
1. C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis.
Claushuis TA; de Vries MK; van der Weijden MA; Visman IM; Nurmohamed MT; Twisk JW; Van der Horst-Bruinsma IE; Crusius JB
Clin Exp Rheumatol; 2015; 33(2):159-65. PubMed ID: 25603416
[TBL] [Abstract][Full Text] [Related]
2. The relationship between C-reactive protein rs3091244 polymorphism and ankylosing spondylitis.
Akbal A; Reşorlu H; Gökmen F; Savaş Y; Zateri Ç; Sargin B; Bozkurt E; Sılan F; Özdemir Ö
Int J Rheum Dis; 2016 Jan; 19(1):43-8. PubMed ID: 26480896
[TBL] [Abstract][Full Text] [Related]
3. The relationship between CRP gene polymorphism (rs2794521, rs3091244), ASDAS-CRP and ASDAS-ESR in ankylosing spondylitis.
Kasapoğlu Aksoy M; Altan L; Görükmez O; Güner A; Ayar K
Mod Rheumatol; 2020 Jul; 30(4):715-720. PubMed ID: 31267817
[No Abstract] [Full Text] [Related]
4. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
[TBL] [Abstract][Full Text] [Related]
5. Association between C-reactive protein gene variant and treatment efficacy of etanercept in ankylosing spondylitis patients receiving hip arthroplasty.
Xu Y; Jiang W; Zhang H
J Clin Lab Anal; 2020 Aug; 34(8):e23343. PubMed ID: 32311164
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese.
Morita A; Nakayama T; Doba N; Hinohara S; Soma M
Hypertens Res; 2006 May; 29(5):323-31. PubMed ID: 16832152
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the C-reactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: The Health 2000 Survey.
Kettunen T; Eklund C; Kähönen M; Jula A; Päivä H; Lyytikäinen LP; Hurme M; Lehtimäki T
Scand J Clin Lab Invest; 2011 Sep; 71(5):353-61. PubMed ID: 21413847
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in the IL-12B gene in association with IL-23 and IL-12p40 serum levels in ankylosing spondylitis.
Ivanova M; Manolova I; Miteva L; Gancheva R; Stoilov R; Stanilova S
Rheumatol Int; 2019 Jan; 39(1):111-119. PubMed ID: 30443744
[TBL] [Abstract][Full Text] [Related]
9. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.
Kathiresan S; Larson MG; Vasan RS; Guo CY; Gona P; Keaney JF; Wilson PW; Newton-Cheh C; Musone SL; Camargo AL; Drake JA; Levy D; O'Donnell CJ; Hirschhorn JN; Benjamin EJ
Circulation; 2006 Mar; 113(11):1415-23. PubMed ID: 16534007
[TBL] [Abstract][Full Text] [Related]
10. Association between CRP gene polymorphisms and the risk of preeclampsia in Han Chinese women.
Wang Y; Wang Q; Guo C; Wang S; Wang X; An L; Cao X; Qiu Y; Wang G; Li H; Ma X
Genet Test Mol Biomarkers; 2014 Nov; 18(11):775-80. PubMed ID: 25314633
[TBL] [Abstract][Full Text] [Related]
11. CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients.
Ammitzbøll CG; Steffensen R; Bøgsted M; Hørslev-Petersen K; Hetland ML; Junker P; Johansen JS; Pødenphant J; Østergaard M; Ellingsen T; Stengaard-Pedersen K
Arthritis Res Ther; 2014 Oct; 16(5):475. PubMed ID: 25359432
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms.
Haroon N; Tsui FW; Chiu B; Tsui HW; Inman RD
J Rheumatol; 2010 Sep; 37(9):1907-10. PubMed ID: 20595269
[TBL] [Abstract][Full Text] [Related]
13. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
[TBL] [Abstract][Full Text] [Related]
14. Serum High-Sensitive C-Reactive Protein Level and CRP Genetic Polymorphisms Are Associated with Abdominal Aortic Aneurysm.
Shangwei Z; Yingqi W; Jiang X; Zhongyin W; Juan J; Dafang C; Yonghua H; Wei G
Ann Vasc Surg; 2017 Nov; 45():186-192. PubMed ID: 28549956
[TBL] [Abstract][Full Text] [Related]
15. Allelic variation at the C-reactive protein gene associates to both hand osteoarthritis severity and serum high sensitive C-reactive protein levels in the GARP study.
Bos SD; Suchiman HE; Kloppenburg M; Houwing-Duistermaat JJ; le Graverand MP; Seymour AB; Kroon HM; Slagboom PE; Meulenbelt I
Ann Rheum Dis; 2008 Jun; 67(6):877-9. PubMed ID: 18055473
[TBL] [Abstract][Full Text] [Related]
16. Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study.
Nam B; Koo BS; Lee TH; Shin JH; Kim JJ; Lee S; Joo KB; Kim TH
BMC Musculoskelet Disord; 2021 Feb; 22(1):140. PubMed ID: 33541326
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to ERAP1 gene single nucleotide polymorphism modulates the inflammatory cytokine setting in ankylosing spondylitis.
Hemmatzadeh M; Babaie F; Ezzatifar F; Mohammadi FS; Ebrazeh M; Golabi Aghdam S; Hajaliloo M; Azizi G; Gowhari Shabgah A; Shekari N; Sehati N; Hosseinzadeh R; Mohammadi H; Babaloo Z
Int J Rheum Dis; 2019 Apr; 22(4):715-724. PubMed ID: 30740926
[TBL] [Abstract][Full Text] [Related]
19. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
Vastesaeger N; Cruyssen BV; Mulero J; Gratacós Masmitjá J; Zarco P; Almodovar R; Font P; Juanola X; Collantes-Estevez E;
Reumatol Clin; 2014; 10(4):204-9. PubMed ID: 24598027
[TBL] [Abstract][Full Text] [Related]
20. Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort.
Machado P; Navarro-Compán V; Landewé R; van Gaalen FA; Roux C; van der Heijde D
Arthritis Rheumatol; 2015 Feb; 67(2):408-13. PubMed ID: 25332195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
